Andrew J. Storaska, Ph.D.

Dan Shores

Andrew J. Storaska, Ph.D. is a patent agent with Rothwell Figg who is experienced in a wide variety of patent law matters, including patent prosecution in the chemical, pharmaceutical, and biotechnology arts. In his current role, he handles various aspects of patent prosecution, conducts prior art searches, and performs patent landscape analysis.

Posts by Andrew J. Storaska, Ph.D.

The mRNA IP and Competitive Landscape: Translate BIO; Arcturus; eTheRNA and Other Startups; and LNP Technology (Part II)

In Part I of this three-part series, we focused on three market players: BioNTech, Moderna and CureVac. In this second post, we will focus on Translate BIO, …

The mRNA IP and Competitive Landscape Through One Year of the COVID-19 Pandemic – Part I

Shortly after we posted about Moderna, Inc.’s October 2020 pledge not to enforce its COVID-19-related patents during the pandemic, the United States Food & Drug Administration (FDA) …